• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

    7/23/24 7:17:00 PM ET
    $APO
    $AVTR
    $HIBB
    $QDEL
    Investment Managers
    Finance
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $APO alert in real time by email

    NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:

    • Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp. (NASD:QDEL) in the S&P MidCap 400, and QuidelOrtho will replace Hibbett Inc. (NASD:HIBB) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 26. JD Sports Fashion Plc (XLON: JD) is acquiring Hibbett in a deal expected to close soon pending final closing conditions.



    • Schneider National Inc. (NYSE:SNDR) will replace U.S. Silica Holdings Inc. (NYSE:SLCA) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 31. Apollo Global Management Inc. (NYSE:APO) is acquiring U.S. Silica Holdings in a deal expected to close soon pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    July 26, 2024

    S&P MidCap 400

    Addition

    Avantor

    AVTR

    Health Care

    July 26, 2024

    S&P MidCap 400

    Deletion

    QuidelOrtho

    QDEL

    Health Care

    July 26, 2024

    S&P SmallCap 600

    Addition

    QuidelOrtho

    QDEL

    Health Care

    July 26, 2024

    S&P SmallCap 600

    Deletion

    Hibbett

    HIBB

    Consumer Discretionary

    July 31, 2024

    S&P SmallCap 600

    Addition

    Schneider National

    SNDR

    Industrials

    July 31, 2024

    S&P SmallCap 600

    Deletion

    U.S. Silica Holdings

    SLCA

    Energy

    For more information about S&P Dow Jones Indices, please visit www.spdji.com

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/avantor-set-to-join-sp-midcap-400-quidelortho--schneider-national-to-join-sp-smallcap-600-302204642.html

    SOURCE S&P Dow Jones Indices

    Get the next $APO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APO
    $AVTR
    $HIBB
    $QDEL

    CompanyDatePrice TargetRatingAnalyst
    Avantor Inc.
    $AVTR
    12/17/2025$9.00Hold → Underperform
    Jefferies
    Avantor Inc.
    $AVTR
    12/15/2025$13.00Buy → Neutral
    BofA Securities
    Apollo Global Management Inc. (New)
    $APO
    12/11/2025$186.00Buy
    UBS
    Schneider National Inc.
    $SNDR
    12/3/2025$28.00Mkt Perform → Outperform
    Raymond James
    Apollo Global Management Inc. (New)
    $APO
    11/20/2025$180.00Equal-Weight → Overweight
    Morgan Stanley
    Avantor Inc.
    $AVTR
    11/4/2025Outperform → Mkt Perform
    Raymond James
    Schneider National Inc.
    $SNDR
    10/31/2025$25.00 → $23.00Buy
    TD Cowen
    Avantor Inc.
    $AVTR
    10/30/2025$12.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $APO
    $AVTR
    $HIBB
    $QDEL
    SEC Filings

    View All

    Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Avantor, Inc. (0001722482) (Filer)

    12/18/25 8:17:12 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    S&P Global Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - S&P Global Inc. (0000064040) (Filer)

    12/16/25 4:05:25 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Avantor, Inc. (0001722482) (Filer)

    12/4/25 4:29:41 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $APO
    $AVTR
    $HIBB
    $QDEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Innovating Diagnostics and What's Next

    SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ:QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Siegrist, PhD, Executive Vice President of Research & Development and Chief Technology Officer at QuidelOrtho. Dr. Siegrist is a recognized leader in molecular diagnostics and biomedical engineering, driving innovation and next-generation diagnostic solutions. Key insights include: Faster cardiac care: High-sensitivity troponin testing accelerates diagnosis and treatment for cardiac pat

    12/18/25 9:17:00 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Schneider's Cowan acquisition delivers major Dedicated growth in first year

    Integration of Cowan strengthens Schneider's reliable Dedicated capabilities, creating value for customers nationwide Schneider National, Inc. (NYSE:SNDR), a premier multimodal provider of transportation, intermodal and logistics services, is marking the one-year anniversary of its acquisition of Cowan Systems, LLC. Over the past twelve months, Schneider has significantly expanded and strengthened its Dedicated operations — building on Cowan's regional expertise, lightweight equipment and innovative solutions to deliver more capacity and efficiency for shippers nationwide. The successful addition of Cowan underscores Schneider's proven approach to acquisitions and continues the expansion

    12/18/25 9:15:00 AM ET
    $SNDR
    Trucking Freight/Courier Services
    Industrials

    S&P 500 Q3 2025 Buybacks Post Modest 6.2% Gain to $249.0 Billion After Declining 20.1% Amidst Uncertainty in Q2; Q4 2025 Expenditures Expected to Post Similar Growth, As 2025 Anticipates a Record $1 Trillion

    S&P 500 Q3 2025 buybacks were $249.0 billion, as the expenditure increased 6.2% from Q2's $234.6 billion and down 15.1% from the record Q1 2025 $293.5 billion, and was up 9.9% from Q3 2024's $226.6 billionThe 12-month September 2025 expenditure was a record $1.020 trillion and was up 11.1% from the 12-month September 2024 expenditure of $918.4 billion Health Care and Financials significantly increased their spending, up 32.2% and 26.3% respectively over Q2 2025, as Materials and Real Estate reduced spending by 21.0% and 40.3%, respectivelyThe net buyback 1% tax reduced Q3 2025 operating earnings, which are set to post a quarterly earnings record by 0.36% and As Reported GAAP by 0.41%, as the

    12/18/25 9:00:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APO
    $AVTR
    $HIBB
    $QDEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rhoads Ann D bought $21,206 worth of shares (750 units at $28.27), increasing direct ownership by 5% to 15,021 units (SEC Form 4)

    4 - QuidelOrtho Corp (0001906324) (Issuer)

    12/10/25 6:37:17 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Mehra Sanjeev K was granted 8,106 shares and bought $3,881,500 worth of shares (350,000 units at $11.09) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    12/9/25 5:11:24 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Mehra Sanjeev K

    3 - Avantor, Inc. (0001722482) (Issuer)

    12/9/25 5:07:43 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $APO
    $AVTR
    $HIBB
    $QDEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rhoads Ann D bought $21,206 worth of shares (750 units at $28.27), increasing direct ownership by 5% to 15,021 units (SEC Form 4)

    4 - QuidelOrtho Corp (0001906324) (Issuer)

    12/10/25 6:37:17 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Mehra Sanjeev K was granted 8,106 shares and bought $3,881,500 worth of shares (350,000 units at $11.09) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    12/9/25 5:11:24 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Wilkins Joseph D Jr. bought $10,343 worth of shares (370 units at $27.95), increasing direct ownership by 3% to 11,876 units (SEC Form 4)

    4 - QuidelOrtho Corp (0001906324) (Issuer)

    12/1/25 4:33:10 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $APO
    $AVTR
    $HIBB
    $QDEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avantor downgraded by Jefferies with a new price target

    Jefferies downgraded Avantor from Hold to Underperform and set a new price target of $9.00

    12/17/25 8:49:45 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Avantor downgraded by BofA Securities with a new price target

    BofA Securities downgraded Avantor from Buy to Neutral and set a new price target of $13.00

    12/15/25 9:53:32 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    UBS resumed coverage on Apollo Global Management with a new price target

    UBS resumed coverage of Apollo Global Management with a rating of Buy and set a new price target of $186.00

    12/11/25 9:02:43 AM ET
    $APO
    Investment Managers
    Finance

    $APO
    $AVTR
    $HIBB
    $QDEL
    Leadership Updates

    Live Leadership Updates

    View All

    Avantor® Appoints Simon Dingemans to its Board of Directors

    RADNOR, Pa., Dec. 18, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Simon Dingemans to its Board of Directors, effective January 2, 2026. Mr. Dingemans is an accomplished executive with extensive global leadership experience across healthcare, finance and strategic business transformation. He was previously the Chief Financial Officer of GlaxoSmithKline plc, a Partner at Goldman Sachs, and a Managing Dire

    12/18/25 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    S&P Global Adds Hubert Joly to its Board of Directors

    NEW YORK, Dec. 16, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) announced today that its Board of Directors has approved the addition of Mr. Hubert Joly to the Board, effective January 2, 2026. Mr. Joly is the former Chair and Chief Executive Officer at Best Buy and is now a senior lecturer at Harvard Business School. Earlier in his career, Mr. Joly served as President and CEO of Carlson, a global hospitality and travel company. In addition to his teaching post at Harvard, Mr. Joly is a member of the Board of Directors of Johnson & Johnson and was until recently on the Board of

    12/16/25 8:05:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Global Announces Mobility Business Chief Financial Officer

    Matt Calderone, outgoing CFO of Booz Allen, named new CFO of Mobility and will lead the finance function of the standalone company NEW YORK, Dec. 16, 2025 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced the appointment of Matt Calderone as Chief Financial Officer (CFO) of the Mobility business, joining the company by March 1, 2026. Mr. Calderone will serve as the CFO of the standalone public company through its planned separation from S&P Global and will oversee all aspects of the company's Finance function. He will report to Mr. Bill Eager, President of S&P Global Mobility, and CEO-designate of the future standalone company.

    12/16/25 7:00:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APO
    $AVTR
    $HIBB
    $QDEL
    Financials

    Live finance-specific insights

    View All

    S&P 500 Q3 2025 Buybacks Post Modest 6.2% Gain to $249.0 Billion After Declining 20.1% Amidst Uncertainty in Q2; Q4 2025 Expenditures Expected to Post Similar Growth, As 2025 Anticipates a Record $1 Trillion

    S&P 500 Q3 2025 buybacks were $249.0 billion, as the expenditure increased 6.2% from Q2's $234.6 billion and down 15.1% from the record Q1 2025 $293.5 billion, and was up 9.9% from Q3 2024's $226.6 billionThe 12-month September 2025 expenditure was a record $1.020 trillion and was up 11.1% from the 12-month September 2024 expenditure of $918.4 billion Health Care and Financials significantly increased their spending, up 32.2% and 26.3% respectively over Q2 2025, as Materials and Real Estate reduced spending by 21.0% and 40.3%, respectivelyThe net buyback 1% tax reduced Q3 2025 operating earnings, which are set to post a quarterly earnings record by 0.36% and As Reported GAAP by 0.41%, as the

    12/18/25 9:00:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    Schneider National, Inc. to report Fourth Quarter 2025 Earnings on January 29, 2026

    Schneider (NYSE:SNDR), a premier multimodal provider of transportation, intermodal and logistics services, today announced it will report its fourth quarter 2025 results after market close on Thursday, January 29, 2026. The Company will hold a conference call to discuss results at 4:30 p.m. Eastern Time that day. Conference call details: Date: January 29, 2026 Time: 4:30 p.m. ET Dial-In-Numbers: 800-715-9871 (toll-free) 646-307-1963 Conference ID: 2793697 The Company will also host a live webcast of its conference call, which may be accessed in the Investor Relations section of the Company's website (schneider.com), along with the current quarterly investor presentation. About Sc

    12/18/25 9:00:00 AM ET
    $SNDR
    Trucking Freight/Courier Services
    Industrials

    KBW Announces Index Rebalancing for Fourth-Quarter 2025

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE:SF), announces the upcoming index rebalancing for the fourth quarter of 2025. This quarter, there are constituent changes within six of our indexes: KBW Nasdaq Insurance Index (Index Ticker: KIX), KBW Nasdaq Regional Banking Index (Index Ticker: KRX, ETF Ticker: KBWR), KBW Nasdaq Financial Sector Dividend Yield Index (Index Ticker: KDX, ETF Ticker: KBWD), KBW Nasdaq Premium Yield Equity REIT Index (Index Ticker: KYX, ETF Ticker: KBWY), KBW Nasdaq Property and Casualty Ins

    12/12/25 8:30:00 PM ET
    $AAT
    $ACIW
    $AJG
    Real Estate Investment Trusts
    Real Estate
    Computer Software: Prepackaged Software
    Technology

    $APO
    $AVTR
    $HIBB
    $QDEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation

    SC 13G/A - QuidelOrtho Corp (0001906324) (Subject)

    12/6/24 10:11:24 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13D/A filed by QuidelOrtho Corporation

    SC 13D/A - QuidelOrtho Corp (0001906324) (Subject)

    11/21/24 5:10:19 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation

    SC 13G/A - QuidelOrtho Corp (0001906324) (Subject)

    11/14/24 1:28:35 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care